Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the company in more than a decade.

Citadel has taken a short position worth 305 million pounds ($384.5 million) in GSK stock, representing a 0.51% stake, ...

(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...

Griffin voiced his concern over Trump's approach towards tariffs, stating that the "bombastic rhetoric" has already caused ...

A microchip materials manufacturer that counts Taiwan Semiconductor, GlobalFoundries and STMicroelectronics as clients saw ...

Citadel, the hedge fund owned by billionaire Ken Griffin, has taken a short position in GlaxoSmithKline (NYSE:GSK), a British ...

Ken Griffin of Citadel bought 1.1 million shares of Tesla ... So, investors need to familiarize themselves with Tesla and ...

Ken Griffin’s Citadel wins big. Soitec cites worsening automotive market for warning. Last Updated: Feb. 6, 2025 at 6:38 a.m. ET First Published: Feb. 6, 2025 at 5:48 a.m. ET ...

Citadel, the hedge fund giant run by Ken Griffin, had a short position equal to 0.6% of the company, according to a disclosure form filed with France's stock-market regulator earlier this week.

Tech stocks can be quite volatile, and this one looks particularly expensive. So, what can you buy instead? The post ...

The long-touted Midtown skyscraper being developed through a partnership that includes billionaire Ken Griffin is scheduled to kick off its public review next month, according to an application filed ...